The proposed competitive renewal study seeks to test a comprehensive model of buffers of disability and diminished quality of life for community- dwelling elderly with and without arthritis. We will examine how quality of medical care and proactive adaptations undertaken by old-old adults (80+) lessen the adverse impact of arthritis on their ability to function and help maximize the quality of their lives. Physicians and patients are seen as partners in care, with the patient-responsive medical care of physicians enhancing the proactive adaptations (physical activity and environmental modifications) of patients. The proposed research will extend our prior NEOMAMDC-funded longitudinal study in both time and space. We will obtained a long term longitudinal follow-up of our original Florida-based elderly cohort. In addition, we will extend our research from relatively healthy and affluent adults living in sunbelt retirement communities to now also include a broader cross-section of urban elderly and racial minorities, and thereby consider the process of arthritis- related disablement in an increasingly frail population of community- living elders of diverse racial and socioeconomic backgrounds. We will collects three annual waves of data based on in-home interviews of an estimated 419 respondents in Florida and 3865 respondents in Cleveland. A combined sample of 658 elderly persons is projected for the third year follow-up. Additionally, we will use least squares regression, structural equations, and latent growth curve analysis to test our comprehensive causal model regarding buffers of the disability cascade. More specifically, we will examine the buffering effect of patient-responsive medical care and proactive adaptation on the progression from arthritis to disability and diminished quality of life. Findings from the proposed study will be useful to clinicians, service providers, policy makers, and others attempting to minimize arthritis-induced disability and enhance quality of life among the elderly.

Project Start
2001-07-01
Project End
2003-06-30
Budget Start
Budget End
Support Year
23
Fiscal Year
2001
Total Cost
$38,258
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Miwa, Hazuki E; Gerken, Thomas A; Huynh, Tru D et al. (2009) Conserved sequence in the aggrecan interglobular domain modulates cleavage by ADAMTS-4 and ADAMTS-5. Biochim Biophys Acta 1790:161-72
Atif, U; Philip, A; Aponte, J et al. (2008) Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians. Osteoarthritis Cartilage 16:1174-7
Kraus, V B; Jordan, J M; Doherty, M et al. (2007) The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. Osteoarthritis Cartilage 15:120-7
Miwa, Hazuki E; Gerken, Thomas A; Huynh, Tru D et al. (2006) Mammalian expression of full-length bovine aggrecan and link protein: formation of recombinant proteoglycan aggregates and analysis of proteolytic cleavage by ADAMTS-4 and MMP-13. Biochim Biophys Acta 1760:472-86
Holderbaum, D; Malvitz, T; Ciesielski, C J et al. (2005) A newly described hereditary cartilage debonding syndrome. Arthritis Rheum 52:3300-4
Denko, Charles W; Malemud, Charles J (2005) Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases. Semin Arthritis Rheum 35:24-34
Ievers-Landis, Carolyn E; Burant, Christopher; Drotar, Dennis et al. (2005) A randomized controlled trial for the primary prevention of osteoporosis among preadolescent girl scouts: 1-year outcomes of a behavioral program. J Pediatr Psychol 30:155-65
Vashishth, D (2005) Collagen glycation and its role in fracture properties of bone. J Musculoskelet Neuronal Interact 5:316
Denko, Charles W; Malemud, Charles J (2005) Serum growth hormone and insulin but not insulin-like growth factor-1 levels are elevated in patients with fibromyalgia syndrome. Rheumatol Int 25:146-51
Denko, Charles W; Malemud, Charles J (2004) Age-related changes in serum growth hormone, insulin-like growth factor-1 and somatostatin in system lupus erythematosus. BMC Musculoskelet Disord 5:37

Showing the most recent 10 out of 92 publications